363 related articles for article (PubMed ID: 33231569)
1. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
[TBL] [Abstract][Full Text] [Related]
2. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes.
Yang J; Chen T; Zhou Y
Hereditas; 2021 Jan; 158(1):4. PubMed ID: 33397514
[TBL] [Abstract][Full Text] [Related]
3. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
[TBL] [Abstract][Full Text] [Related]
4. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
[TBL] [Abstract][Full Text] [Related]
5. Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.
Chai P; Yu J; Ge S; Jia R; Fan X
J Hematol Oncol; 2020 May; 13(1):43. PubMed ID: 32366279
[TBL] [Abstract][Full Text] [Related]
6. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
7. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
Uddin MN; Akter R; Li M; Abdelrahman Z
Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
[TBL] [Abstract][Full Text] [Related]
8. Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection.
Rajput SK; Logsdon DM; Kile B; Engelhorn HJ; Goheen B; Khan S; Swain J; McCormick S; Schoolcraft WB; Yuan Y; Krisher RL
F S Sci; 2021 Feb; 2(1):33-42. PubMed ID: 33521687
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
10. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H
J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084
[TBL] [Abstract][Full Text] [Related]
11. Female reproductive tract has low concentration of SARS-CoV2 receptors.
Goad J; Rudolph J; Rajkovic A
PLoS One; 2020; 15(12):e0243959. PubMed ID: 33315943
[TBL] [Abstract][Full Text] [Related]
12. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
14. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
15. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
16. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
Muus C; Luecken MD; Eraslan G; Sikkema L; Waghray A; Heimberg G; Kobayashi Y; Vaishnav ED; Subramanian A; Smillie C; Jagadeesh KA; Duong ET; Fiskin E; Torlai Triglia E; Ansari M; Cai P; Lin B; Buchanan J; Chen S; Shu J; Haber AL; Chung H; Montoro DT; Adams T; Aliee H; Allon SJ; Andrusivova Z; Angelidis I; Ashenberg O; Bassler K; Bécavin C; Benhar I; Bergenstråhle J; Bergenstråhle L; Bolt L; Braun E; Bui LT; Callori S; Chaffin M; Chichelnitskiy E; Chiou J; Conlon TM; Cuoco MS; Cuomo ASE; Deprez M; Duclos G; Fine D; Fischer DS; Ghazanfar S; Gillich A; Giotti B; Gould J; Guo M; Gutierrez AJ; Habermann AC; Harvey T; He P; Hou X; Hu L; Hu Y; Jaiswal A; Ji L; Jiang P; Kapellos TS; Kuo CS; Larsson L; Leney-Greene MA; Lim K; Litviňuková M; Ludwig LS; Lukassen S; Luo W; Maatz H; Madissoon E; Mamanova L; Manakongtreecheep K; Leroy S; Mayr CH; Mbano IM; McAdams AM; Nabhan AN; Nyquist SK; Penland L; Poirion OB; Poli S; Qi C; Queen R; Reichart D; Rosas I; Schupp JC; Shea CV; Shi X; Sinha R; Sit RV; Slowikowski K; Slyper M; Smith NP; Sountoulidis A; Strunz M; Sullivan TB; Sun D; Talavera-López C; Tan P; Tantivit J; Travaglini KJ; Tucker NR; Vernon KA; Wadsworth MH; Waldman J; Wang X; Xu K; Yan W; Zhao W; Ziegler CGK; ;
Nat Med; 2021 Mar; 27(3):546-559. PubMed ID: 33654293
[TBL] [Abstract][Full Text] [Related]
17. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.
Tribolet L; Alexander MR; Brice AM; van Vuren PJ; Rootes CL; Mara K; McDonald M; Bruce KL; Gough TJ; Shi S; Cowled C; Bean AGD; Stewart CR
J Virol; 2021 Jul; 95(15):e0032721. PubMed ID: 33963054
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.
Mariappan V; S R R; Balakrishna Pillai A
IUBMB Life; 2020 Dec; 72(12):2533-2545. PubMed ID: 33031602
[TBL] [Abstract][Full Text] [Related]
19. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.
Ragia G; Manolopoulos VG
Pharmacogenomics; 2020 Dec; 21(18):1311-1329. PubMed ID: 33243086
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.
Huang X; He C; Hua X; Kan A; Sun S; Wang J; Li S
Int J Biol Sci; 2020; 16(13):2464-2476. PubMed ID: 32760213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
